* Outset Medical Inc OM.OQ reported a quarterly adjusted
loss
of 78 cents per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -90 cents. The mean expectation of eight analysts for the
quarter was for a loss of 55 cents per share. Wall Street
expected results to range from -62 cents to -44 cents per share.
* Revenue fell 15.8% to $28.17 million from a year ago;
analysts
expected $30.34 million.
* Outset Medical Inc's reported EPS for the quarter was a
loss
of 78 cents.
* The company reported a quarterly loss of $39.94 million.
* Outset Medical Inc shares had risen by 86.0% this
quarter and
lost 23.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 6.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* Wall Street's median 12-month price target for Outset
Medical
Inc is $6.00
This summary was machine generated from LSEG data May 9 at 11:45
a.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.55 -0.78 Missed
Dec. 31 2023 -0.61 -0.59 Beat
Sep. 30 2023 -0.67 -0.71 Missed
Jun. 30 2023 -0.76 -0.90 Missed